Cloning and expression of single chain variable fragment antibodies against two ectodomains of human CD133

Wang Fei,Zhao Jing,Wang Shunjuan,Xia Haibin
DOI: https://doi.org/10.3969/j.issn.1672-4992.2013.05.08
2013-01-01
Journal of Modern Oncology
Abstract:Objective:To clone and express the single chain variable fragment antibodies(scFv) against two ectodomains of human CD133.Methods:Total mRNA was extracted from the hybridoma cells that can secrete monoclonal antibodies recognizing different ectodomains of human CD133 molecule.The encoding sequences of the heavy chain(VH) and light chain(VL) were successfully obtained using degenerate PCR.Then we joined the VH and VL genes with a flexible linker(GGGGS) 3 by overlap extension PCR,after that we respectively cloned the CD133 Ex-1 scFv or CD133 Ex-2 scFv into the pRSET-B vector that with a 6×His tag on N-terminus.The expression and identification of CD133 Ex-1 scFv and CD133 Ex-2 scFv were examined after construction.Results:We successfully cloned and linked the VH and VL genes to construct two single chain variable fragment antibodies that respectively against the two ectodomains of human CD133.After expressed in E.coli,the production of the two scFvs was identified by Western blot assay using His tag mAb.Conclusion:The single chain variable fragment antibodies were expressed in E.coli in the form of inclusion-body in cytoplasm.Then the inclusion-body was renatured and purified by Ni-NTA resin to obtain the scFv antibody with high purity.We believe that construction and application of these scFvs could shed light on the investigation of the function of human CD133 molecule and,more importantly,develop novel tumor targeting therapy.
What problem does this paper attempt to address?